This review examines a well-characterized factor, interleukin 1 (IL-1), that has recently received considerable attention. A level of understanding is emerging that goes beyond simple recognition that IL-1 plays a role in disease, and begins to explain the molecular mechanisms of function. This review summarizes some current information on the importance of IL-1 in periodontitis as well as the signal transduction of IL-1, from binding to its cell-surface receptors, to the activation of cytoplasmic mediators and transcription factors responsible for the induction of target genes. The effect of IL-1 signal transduction is ultimately the activation and repression of specific transcription factors that regulate genes responsible for cellular activities. As additional steps of signal transduction become better-characterized, these insights may facilitate the development of improved therapeutic approaches for controlling inflammation and connective tissue destruction in a variety of diseases.
Adachi O, Kawai T., Takeda K., Matsumoto M., Tsutsui H., Sakagami M., et al. (1998). Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity9:143-150.
2.
Assuma R., Oates T., Cochran D., Amar S., Graves DT (1998). IL-1 and TNF antagonists inhibit the inflammatory response and bone loss in experimental periodontitis. J Immunol160:403-409.
3.
Auron PE (1998). The interleukin 1 receptor: ligand interactions and signal transduction. Cytokine Growth Factor Rev9:221-237.
4.
Auron PE, Webb AC ( 1994). Interleukin-1 : a gene expression system regulated at multiple levels. Eur Cytokine Netw5:573-592.
5.
Baud V., Liu ZG, Bennett B., Suzuki N., Xia Y., Karin M. (1999). Signaling by proinflammatory cytokines: oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an amino-terminal effector domain. Genes Dev13:1297-1308.
6.
Bonnert TP, Garka KE, Parnet P., Sonoda G., Testa JR, Sims JE ( 1997). The cloning and characterization of human MyD88: a member of an IL-1 receptor related family. FEBS Lett402:81-84.
7.
Bom TL, Thomassen E., Bird TA, Sims JE ( 1998). Cloning of a novel receptor subunit, AcPL, required for interleukin-18 signaling. J Biol Chem273:29445-29450.
8.
Bums K., Martinon F., Esslinger C., Pahl H., Schneider P., Bodmer JL, et al. (1998). MyD88, an adapter protein involved in interleukin-1 signaling. J Biol Chem273:12203-12209.
9.
Cao Z., Henzel WJ, Gao X. (1996a). IRAK: a kinase associated with the interleukin-1 receptor. Science271:1128-1131.
10.
Cao Z., Xiong J., Takeuchi M., Kurama T., Goeddel DV (1996b). TRAF6 is a signal transducer for interleukin-1 . Nature (London)383:443-446.
11.
Chiang CY, Kyritsis G., Graves DT, Amar S. ( 1999). Interleukin-1 and tumor necrosis factor activities partially account for calvarial bone resorption induced by local injection of lipopolysaccharide . Infect Immun67:4231-4236.
12.
Chuang TH, Ulevitch RJ (2000). Cloning and characterization of a sub-family of human toll-like receptors: hTLR7, hTLR8, and hTLR9. Eur Cytokine Netw11:372-378.
13.
Colotta F., Re F., Muzio M., Bertini R., Polentarutti N., Sironi M., et al. (1993). Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science261 :472-475.
14.
Contreras A., Slots J. (1996). Mammalian viruses in human periodontitis. Oral Microbiol Immunol11:381-386.
15.
Contreras A., Slots J. (1998). Active cytomegalovirus infection in human periodontitis . Oral Microbiol Immunol13:225-230.
16.
Croston GE, Cao Z., Goeddel DV (1995). NF-Kappa B activation by interleukin-1 (IL-1) requires an IL-1 receptor-associated protein kinase activity. J Biol Chem270:16514-16517.
17.
Cullinan EB, Kwee L., Nunes P., Shuster DJ, Ju G., McIntyre KW, et al. (1998). IL-1 receptor accessory protein is an essential component of the IL-1 receptor. J Immunol161:5614-5620.
18.
De Sanctis M., Zucchelli G. (2000). Interleukin-1 gene polymorphisms and long-term stability following guided tissue regeneration therapy. J Periodontol71 :606-613.
19.
Diehl SR, Wang Y., Brooks CN, Burmeister JA, Califano JV, Wang S., et al. (1999). Linkage disequilibrium of interleukin-1 genetic polymorphisms with early-onset periodontitits. J Periodontol70:418-430.
20.
Dinarello CA (1996). Biological basis for interleukin-1 in disease . Blood87:2095-2147.
21.
Ebersole JL, Singer RE, Steffensen B., Filloon T., Komman KS (1993). Inflammatory mediators and immunoglobulins in GCF from healthy, gingivitis, and periodontitis sites. J Periodontal Res28:543-546.
22.
Engebretson SP, Lamster IB, Herrera-Abreu M., Celenti RS, Timms JM, Chaudhary AG, et al. (1999). The influence of interleukin gene polymorphism on expression of interleukin-1ß and tumor necrosis factor-a in periodontal tissue and gingival crevicular fluid. J Periodontol70:567-573.
23.
Finzel BC, Clancy LL, Holland DR, Muchmore SW, Watenpaugh KD, Einspahr HM (1989). Crystal structure of recombinant human interleukin-1 beta at 2.0 A resolution. J Mol Biol209:779-791.
24.
Galbraith GM, Hagan C., Steed RB, Sanders JJ, Javed T. (1997). Cytokine production by oral and peripheral blood neutrophils in adult periodontitis. J Periodontol68:832-838.
25.
Gore EA, Sanders JJ, Pandey JP, Palesch Y., Galbraith GM (1998). Interleukin-1 beta +3953 allele 2: association with disease status in adult periodontitis. J Clin Periodontol25:781-785.
26.
Gravallese E., Galson D., Goldring S., Auron P. (2000). The role of TNFreceptor members and other TRAF-dependent receptors in bone resorption. Arthrit Res3:6-12.
27.
Graves BJ, Hatada MH, Hendrickson WA, Miller JK, Madison VS, Satow Y. (1990). Structure of interleukin lalpha at 2.7-A resolution . Biochemistry29:2679-2684.
28.
Greenfeder SA, Nunes P., Kwee L., Labow M., Chizzonite RA, Ju G. (1995). Molecular cloning and characterization of a second subunit of the interleukin I receptor complex. J Biol Chem270:13757-13765.
29.
Hardiman G., Rock FL, Balasubramanian S., Kastelein RA, Bazan JF (1996). Molecular characterization and modular analysis of human MyD88. Oncogene13:2467-2475.
30.
Huang J., Gao X., Li S., Cao Z. (1997). Recruitment of IRAK to the interleukin 1 receptor complex requires interleukin 1 receptor accessory protein. Proc Natl Acad Sci USA94:12829-12832.
31.
Hultmark D. (1994). Macrophage differentiation marker MyD88 is a member of the Toll/IL-1 receptor family. Biochem Biophys Res Commun199:144-146.
32.
Irwin CR, Schor SL, Ferguson MW (1994). Effects of cytokines on gingival fibroblasts in vitro are modulated by the extracellular matrix. J Periodontal Res29:309-317.
33.
Ishida T., Mizushima SI, Azuma S., Kobayashi N., Tojo T., Suzuki K., et al. (1996). Identification of TRAF6, a novel tumor necrosis factor receptor-associated factor protein that mediates signaling from an amino-terminal domain of the CD40 cytoplasmic region. J Biol Chem271:28745-28748.
34.
Kanakaraj P., Ngo K., Wu Y., Angulo A., Ghazal P., Harris CA, et al. (1999a). Defective interleukin (IL)-18-mediated natural killer and T helper cell type I responses in IL-1 receptor-associated kinase (IRAK)-deficient mice. J Exp Med189:1129-1138.
35.
Kanakaraj P., Schafer PH, Cavender DE, Wu Y., Ngo K., Grealish PF, et
36.
Kawai T., Adachi O, Ogawa T., Takeda K., Akira S. (1999). Unresponsiveness of MyD88-deficient mice to endotoxin . Immunity11:115-122.
37.
Kinane DF, Winstanley FP, Adonogianaki E, Moughal NA (1992). Bioassay of interleukin-1 (IL-1) in human gingival crevicular fluid during experimental gingivitis. Arch Oral Biol 37:153-156. Korherr C, Hofmeister R, Wesche H, Falk W (1997). A critical role for interleukin-1 receptor accessory protein in interleukin-1 signaling. Eur J Immunol 27:262-267.
38.
Kornman KS, Crane A., Wang HY, di Giovine FS, Newman MG, Pirk FW, et al. (1997). The interleukin-1 genotype as a severity factor in adult periodontal disease. J Clin Periodontol24:72-77.
39.
Kumar S., McDonnell PC, Lehr R., Tierney L., Tzimas MN, Griswold DE, et al. (2000). Identification and initial characterization of four novel members of the interleukin-1 family. J Biol Chem275:10308-10314.
40.
Lang NP, Tonetti MS, Suter J., Sorrell J., Duff GW, Komman KS (2000). Effect of interleukin-1 gene polymorphisms on gingival inflammation assessed by bleeding on probing in a periodontal maintenance population. J Periodontal Res35:102-107.
41.
Laye S., Lundkvist J., Bartfai T. (1998). Human/mouse interleukin-1 receptor/receptor accessory protein interactions in IL-1ß-induced NFkappaB activation. FEBS Lett429:307-311.
42.
Leon LR, Conn CA, Glaccum M, Kluger MJ (1996). IL-1 type I receptor mediates acute phase response to turpentine, but not lipopolysaccharide, in mice. Am J Physiol 271:R1668-R1675. Li X, Commane M, Bums C, Vithalani K, Cao Z, Stark GR (1999). Mutant cells that do not respond to interleukin-1 (IL-1) reveal a novel role for IL-1 receptor-associated kinase. Mol Cell Biol 19:46434652. Liu CM, Hou LT, Wong MY, Rossomando EF (1996). Relationships between clinical parameters, interleukin 1ß and histopathological findings of gingival tissue in periodontitis patients. Cytokine 8:161-167.
43.
Lo YJ, Liu CM, Wong MY, Hou LT, Chang WK (1999). Interleukin IB-secreting cells in inflamed gingival tissue of adult periodontitis patients. Cytokine11:626-633.
44.
Lord KA, Hoffman-Liebermann B., Liebermann DA (1990). Nucleotide sequence and expression of a cDNA encoding MyD88, a novel myeloid differentiation primary response gene induced by IL6 . Oncogene5:1095-1097.
45.
Malinowsky D., Lundkvist J., Laye S., Bartfai T. (1998). Interleukin-1 receptor accessory protein interacts with the type II interleukin-1 receptor. FEBS Lett429:299-302.
46.
Mark LL, Haffajee AD, Socransky SS, Kent RL, Guerrero D., Kornman K., et al. (2000). Effect of the interleukin-1 genotype on monocyte IL-1B expression in subjects with adult periodontitis. J Periodontal Res35:172-177.
47.
Maschera B., Ray K., Burns K., Volpe F. (1999). Overexpression of an enzymatically inactive interleukin-1-receptor-associated kinase activates nuclear factor-kB. Biochem J339:227-231.
48.
Matsuki Y., Yamamoto T., Hara K. ( 1992). Detection of inflammatory cytokine messenger RNA (mRNA)-expressing cells in human inflamed gingiva by combined in situ hybridization and immunohistochemistry . Immunology76:42-47.
49.
Matsuki Y, Yamamoto T, Hara K (1993). Localization of interleukin-1 (IL-1) mRNA-expressing macrophages in human inflamed gingiva and IL-1 activity in gingival crevicular fluid. J Periodontal Res 28:35-42. McFarlane CG, Reynolds JJ, Meikle MC (1990). The release of
50.
McWhirter SM, Pullen SS, Holten JM, Crute JJ, Kehry MR, Alber T. (1999). Crystallographic analysis of CD40 recognition and signaling by human TRAF2. Proc Natl Acad Sci USA96:8408-8413.
51.
Means TK, Golenbock DT, Fenton MJ (2000). The biology of Toll-like receptors. Cytokine Growth Factor Rev 11:219-232. Medzhitov R, Preston-Hurlburt P, Kopp E, Stadlen A, Chen C, Ghosh S, et al. (1998). MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol Cell 2:253-258.
52.
Muzio M., Ni J., Feng P., Dixit V. (1997). IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling. Science278:1612-1615.
53.
Muzio M, Natoli G, Saccani S, Levrero M, Mantovani A (1998). The human Toll signaling pathway: divergence of nuclear factor kB and JNK/SAPK activation upstream of tumor necrosis factor receptor-associated factor 6 (TRAF6). J Exp Med 187:2097-2101. Ninomiya-Tsuji J, Kishimoto K, Hiyama A, Inoue J, Cao Z, Matsumoto K (1999). The kinase TAK1 can activate the NIK-IkB as well as the MAP kinase cascade in the IL-1 signalling pathway. Nature (London) 398:252-256.
54.
Ohshima M., Otsuka K., Suzuki K. (1994). Interleukin-1 beta stimulates collagenase production by cultured human periodontal ligament fibroblasts. J Periodontal Res29:421-429.
55.
Park YC, Burkitt V., Villa AR, Tong L., Wu H. (1999). Structural basis for self-association and receptor recognition of human TRAF2. Nature (London)398:533-538.
56.
Parkhill JM, Hennig BJ, Chapple IL, Heasman PA, Taylor JJ (2000). Association of interleukin-1 gene polymorphisms with early-onset periodontitis. J Clin Periodontol27:682-689.
57.
Pocoit F, Molvig J, Wogensen L, Worsaae H, Nerub J (1992). A Taq I polymorphism in the human interleukin-1 beta (IL-1ß) gene correlates with secretion in vitro. Eur J Clin Invest 22:396-402. Priestle JP, Schar HP, Grutter MG (1989). Crystallographic refinement of interleukin-1beta at 2.0A- resolution. Proc Natl Acad Sci USA 86:9667-9671.
58.
Rawlinson A., Dalati MH, Rahman S., Walsh TF, Fairclough AL (2000). Interleukin-1 and IL-1 receptor antagonist in gingival crevicular fluid. J Clin Periodontol27:738-743.
59.
Rock FL, Hardiman G., Timans JC, Kastelein RA, Bazan JF (1998). A family of human receptors structurally related to Drosophila Toll. Proc Natl Acad Sci USA95:588-593.
60.
Schreuder H., Tardif C., Trump-Kallmeyer A., Soffientini A., Sarubbi E., Akeson A., et al. (1997). A new cytokine-receptor binding mode revealed by the crystal structure of the IL-1 receptor with an antagonist. Nature (London)386:194-200.
61.
Schytte Blix IJ, Helgeland K., Hvattum E., Lyberg T. (1999). Lipopolysaccharide from Actinobacillus actinomycetemcomitans stimulates production of interleukin-1 beta, tumor necrosis factor-alpha, interleukin-6 and interleukin-1 receptor antagonist in human whole blood. J Periodontal Res34:34-40.
62.
Sims JE, March CJ, Cosman D, Widmer MB, MacDonald HR, McMahan CJ, et al. (1988). cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily. Science 241:585-589. Smith DE, Renshaw BR, Ketchem RR, Kubin M, Garka KE, Sims JE (2000). Four new members expand the interleukin-1 superfamily. J Biol Chem 275:1169-1175.
63.
Socransky SS, Haffajee AD, Smith C., Duff GW ( 2000). Microbiological parameters associated with interleukin-1 genotype in periodontitis patients. J Clin Periodontol27:810-818.
64.
Stashenko P, Fujiyoshi P, Obernesser MS, Prostak L, Haffajee AD, Socransky SS (1991). Levels of interleukin-1ß in tissue from sites of active periodontal disease. J Clin Periodontol 18:548-554. Tabeta K, Yamazaki K, Akashi S, Miyake K, Kumada H, Umemoto T, et al. (2000). Toll-like receptors confer responsiveness to lipopolysaccharide from Porphyromonas gingivalis in human gingival fibroblasts. Infect Immun 68:3731-3735.
65.
Takaesu G., Kishida S., Hiyama A., Yamaguchi K., Shibuya H., Irie K., et al. (2000). TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway. Mol Cell5:649-658.
66.
Takeuchi O, Hoshino K., Kawai T., Sanjo H., Takada H., Ogawa T., et al. (1999). Differential roles of TLR2 and TLR4 in recognition of Gram-positive and Gram-negative cell wall components. Immunity11:443-451.
67.
Teng YT, Nguyen H., Gao X., Kong YY, Gorczynski RM, Singh B., et al. (2000). Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection. J Clin Invest106:R59-R67.
68.
Vigers GP, Caffes P, Evans RJ, Thompson RC, Eisenberg SP, Brandhuber BJ (1994). X-ray structure of interleukin-1 receptor antagonist at 2.0-A resolution. J Biol Chem 269:12874-12879. Vigers GP, Anderson LJ, Caffes P, Brandhuber BJ (1997). Crystal structure of the type-I interleukin-1 receptor complexed with interleukin-1ß. Nature (London) 386:190-194.
69.
Volpe F., Clatworthy J., Kaptein A., Maschera B., Griffin AM, Ray K. (1997). The IL1 receptor accessory protein is responsible for the recruitment of the interleukin-1 receptor associated kinase to the IL1/IL1 receptor I complex. FEBS Lett419:41-44.
70.
Wajant H, Grell M, Scheurich P (1999). TNF receptor associated factors in cytokine signaling. Cytokine Growth Factor Rev 10:15-26. Walker SJ, Van Dyke TE, Rich S, Komman KS, di Giovine FS, Hart TC (2000). Genetic polymorphisms of the IL-lalpha and IL-1beta genes in African-American LJP patients and an African-American control population. J Periodontol 71:723-728.
71.
Wang PL, Azuma Y., Shinohara M., Ohura K. (2000). Toll-like receptor 4-mediated signal pathway induced by Porphyromonas gingivalis lipopolysaccharide in human gingival fibroblasts . Biochem Biophys Res Commun273:1161-1167.
72.
Wara-aswapati N., Yang Z., Waterman WR, Koyama Y., Tetradis S., Choy BK, et al. (1999). Cytomegalovirus IE2 protein stimulates interleukin 1ß gene transcription via tethering to Spi-1/Pu.l. Mol Cell Biol19:6803-6814.
73.
Wesche H., Neumann D., Resch K., Martin MU (1996). Co-expression of mRNA for type I and type II interleukin-1 receptor and IL-1 receptor accessory protein correlates to IL-1 responsiveness . FEBS Lett391:104-108.
74.
Wesche H., Henzel WJ, Shillinglaw W., Li S., Cao Z. (1997a). MyD88: an adapter that recruits IRAK to the IL-1 receptor complex. Immunity7:837-847.
75.
Wesche H., Korherr C., Kracht M., Falk W., Resch K., Martin MU (1997b). The interleukin-1 receptor accessory protein (IL-IRAcp) is essential for IL-1-induced activation of interleukin-1 receptor-associated kinase (IRAK) and stress-activated protein kinases (SAP Kinases). J Biol Chem272:7727-7731.
76.
Wesche H, Resch K, Martin MU (1998). Effects of IL-1 receptor accessory protein on IL-1 binding. FEBS Lett 429:303-306. Wesche H, Gao X, Li X, Kirschning CJ, Stark GR, Cao Z (1999). IRAK-M is a novel member of the Pelle/interleukin-1 receptor-associated kinase (IRAK) family. J Biol Chem 274:19403-19410. Wilson TG, Nunn M (1999). The relationship between the interleukin-1 periodontal genotype and implant loss. initial data. J Periodontol 70:724-729.
77.
Xiao T., Towb P., Wasserman SA, Sprang SR (1999). Three-dimensional structure of a complex between the death domains of Pelle and Tube. Cell99:545-555.
78.
Xu Y., Tao X., Shen B., Horng T., Medzhitov R., Manley JL, et al. (2000). Structural basis for signal transduction by the Toll/interleukin-1 receptor domains. Nature (London)408:111-115.
79.
Yamada H., Mizumo S., Horai R., Iwakura Y., Sugawara I. (2000). Protective role of interleukin-1 in mycobacterial infection in IL-1 alpha/beta double-knockout mice. Lab Invest80:759-767.
80.
Yamin TT, Miller DK (1997). The interleukin-1 receptor-associated kinase is degraded by proteosomes following its phosphorylation. J Biol Chem272:21540-21547.
81.
Yang RB, Mark MR, Gurney AL, Godowski PJ (1999). Signaling events induced by lipopolysaccharide-activated Toll-like receptor 2. J Immunol163:639-643.
82.
Ye H., Park YC, Kreishman M., Kieff E., Wu H. (1999). The structural basis for the recognition of diverse receptor sequences by TRAF2. Mol Cell4:321-330.
83.
Yoon DY, Dinarello CA (1998). Antibodies to domains II and III of the IL-1 receptor accessory protein inhibit IL-1 beta activity but not binding: regulation of IL-1 responses is via type I receptor, not the accessory protein. J Immunol160:3170-3179.
84.
Yoshimura A., Lien E., Ingalls RR, Tuomanen E., Dziarski R., Golenbock D. (1999). Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J Immunol163:1-5.
85.
Zetterstrom M., Lundkvist J., Malinowsky D., Eriksson G., Bartfai T. (1998). Interleukin-1-mediated febrile responses in mice and interleukin-1 beta activation of NFkappaB in mouse primary astrocytes, involves the interleukin-1 receptor accessory protein.
